Biogen’s Alzheimer’s Drug Opens Up a New Market. These Stocks Could Benefit if More Approvals Come.
An enormous market that has eluded drug companies for decades has now been unlocked. When the U.S. Food and Drug
Περισσότερα...Biogen
Biogen Stock Jumps on FDA Approval. What Wall Street Is Saying.
Biogen shares spiked nearly 60% after trading resumed early afternoon Monday, in the wake of the U.S. Food and Drug
Περισσότερα...